Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: The therapeutic effects of human embryonic stem cells-derived immunity-and-matrix regulatory cells on membranous nephropathy

Fig. 5

The proportion of CD4 + CD25 + T cells in circulation and in spleen. The proportion of CD4 + CD25 + T cells in CD4 + T lymphocyte cells was higher in circulation of the two IMRC treated rat groups (a). It was also higher in spleen of the two IMRC treated rat groups (b). *P < 0.05; **P < 0.01; ***P < 0.001

Back to article page